N/A
Manufactured by ANI Pharmaceuticals, Inc.
9 FDA adverse event reports analyzed
Last updated: 2026-04-15
MAGNESIUM SULFATE, UNSPECIFIED FORM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ANI Pharmaceuticals, Inc.. The most commonly reported adverse reactions for MAGNESIUM SULFATE, UNSPECIFIED FORM include BLOOD PRESSURE INCREASED, CHILLS, DRUG INTERACTION, HYPOTONIA, MYALGIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MAGNESIUM SULFATE, UNSPECIFIED FORM.
Out of 2 classified reports for MAGNESIUM SULFATE, UNSPECIFIED FORM:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 9 FDA FAERS reports that mention MAGNESIUM SULFATE, UNSPECIFIED FORM. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include BLOOD PRESSURE INCREASED, CHILLS, DRUG INTERACTION, HYPOTONIA, MYALGIA, NEUROMUSCULAR BLOCK PROLONGED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list ANI Pharmaceuticals, Inc. in connection with MAGNESIUM SULFATE, UNSPECIFIED FORM. Always verify the specific product and NDC with your pharmacist.